Skip to content

AbsorbaTack vs. Non-Absorbable Sutures for Split-Thickness Skin Grafting in Foot Ulcers: A Comparative Study

A comparative study between Application of Absorbable Tacker ABSORBATACK for graft fixation at split skin grafting versus Non absorbable suture for foot ulcer patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084385
Enrollment
50
Registered
2025-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Absorbable, spiral tacking device made of poly(D,L)-lactide (PDLLA): AbsorbaTack is an absorbable, spiral tacking device made of poly(D,L)-lactide (PDLLA), used for split-thickness skin

Sponsors

Saveetha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with raw area of the foot post wound debridement of ulcer requiring skin grafting will be potential participants. They will be assessed to see if they meet the following inclusion criteria: 1. 2. Will be undergoing surgery Age ~18 years.

Exclusion criteria

Exclusion criteria: Pregnancy. Not cognitively intact to consent to participation. Known immunodeficiency (HIV, leukaemia, etc), or haemolytic anaemia. Skin conditions or medications affecting skin thickness and quality (eg, prolonged corticosteroid use, autoimmune conditions of skin). Vascular disorders Chronic malnourishment.

Design outcomes

Primary

MeasureTime frame
Primary outcome is graft take based on wound healing at 1 month.Timepoint: Primary outcome is graft take based on wound healing at 1 month.

Secondary

MeasureTime frame
Secondary outcomes will be pain on dressing changes in operative time duration of postop stay rate of wound healing by looking at percentage of graft acceptance rate of incidence of haematoma seromaTimepoint: Day3 1st month 3rd month

Countries

India

Contacts

Public ContactAnusuya C

Saveetha Medical College & Hospital, Department of General Surgery, Chennai, India

gmkumaran99@gmail.com9712923102

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026